Subtle changes in the eyes can reveal serious health issues like dementia, diabetes, and high cholesterol. The eyes can ...
Developed internally at Lilly, Kisunla is the first and only amyloid plaque-targeting therapy ... is the first clinically validated cell therapy for corneal care. The drug treats corneal ...
The RESTORE VISION scientific team has identified seven rare ocular conditions that impact the cornea and the rest of the ocular surface. "With a comprehensive approach, we aim to restore the ...
McDade said this study has the longest-running data for any patients who started amyloid-lowering biologics while they were still free of symptoms. “We think that there’s a delay in the ...
Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...
Share on Pinterest An experimental stem cell therapy could help reverse corneal damage in people with a vision-threatening eye condition. Image credit: daliloveart/Getty Images. Researchers ...
Please provide your email address to receive an email when new articles are posted on . Allogenic corneal inlays are highly biocompatible and easy to implant. They offer a simple, safe solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results